Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma

被引:0
作者
Laurence Legros
Alina Pascale
Catherine Guettier
Pirayeh Eftekhari
Yasmina Ben Merabet
Maryse Stang
Rachel Bossevot
Emma Goldschmidt
Ayhan Ulusakarya
Stephane Morisset
Maïté Lewin
Didier Samuel
Olivier Rosmorduc
机构
[1] Hôpital Bicêtre,Department of Clinical Hematology
[2] AP-HP,Hepato
[3] INSERM UMRS-MD-1197,Biliary Department
[4] Université Paris-Saclay,Anatomic Pathology Department
[5] France Intergroupe Syndromes Myéloprolifératifs (FIM),Medical Oncology Department
[6] Hôpital Paul Brousse,Radiology Department
[7] AP-HP,undefined
[8] Hôpital Bicêtre,undefined
[9] AP-HP,undefined
[10] Hôpital Paul Brousse,undefined
[11] AP-HP,undefined
[12] Independent Biostatistician,undefined
[13] Hôpital Paul Brousse,undefined
[14] AP-HP,undefined
[15] INSERM U1193,undefined
[16] Université Paris-Saclay,undefined
[17] Sorbonne Université,undefined
来源
Cancer Chemotherapy and Pharmacology | 2023年 / 91卷
关键词
Hepatocellular carcinoma; Lenvatinib; Antiangiogenic drugs; Erythrocytosis; Erythropoietin; Thromboprophylaxis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:337 / 344
页数:7
相关论文
共 135 条
[81]  
Duskin-Bitan H(undefined)undefined undefined undefined undefined-undefined
[82]  
Leibner A(undefined)undefined undefined undefined undefined-undefined
[83]  
Amitai O(undefined)undefined undefined undefined undefined-undefined
[84]  
Koury ST(undefined)undefined undefined undefined undefined-undefined
[85]  
Bondurant MC(undefined)undefined undefined undefined undefined-undefined
[86]  
Koury MJ(undefined)undefined undefined undefined undefined-undefined
[87]  
McFadzean AJ(undefined)undefined undefined undefined undefined-undefined
[88]  
Todd D(undefined)undefined undefined undefined undefined-undefined
[89]  
Tsang KC(undefined)undefined undefined undefined undefined-undefined
[90]  
Kew MC(undefined)undefined undefined undefined undefined-undefined